Amylyx Pharmaceuticals, Inc.

NasdaqGS AMLX

Amylyx Pharmaceuticals, Inc. Share Price on January 14, 2025: USD 3.13

Amylyx Pharmaceuticals, Inc. Share Price is USD 3.13 on January 14, 2025, a -79.83% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.

Amylyx Pharmaceuticals, Inc. 52-week high Share Price is USD 19.57 on February 28, 2024, which is 525.24% above the current Share Price.
Amylyx Pharmaceuticals, Inc. 52-week low Share Price is USD 1.62 on June 18, 2024, which is -48.24% below the current Share Price.
Amylyx Pharmaceuticals, Inc. average Share Price for the last 52 weeks is USD 4.97.

Key data

Date	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)

NasdaqGS: AMLX

Amylyx Pharmaceuticals, Inc.

CEO	Mr. Joshua B. Cohen
IPO Date	Jan. 7, 2022
Location	United States
Headquarters	43 Thorndike Street
Employees	384
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis. It is also developing AMX0035 for other neurodegenerative diseases. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.

Key trends

Past 5 years